-
Interpol backroom warriors fight cyber criminals 'weaponising' AI
-
New world for users and brands as ads hit AI chatbots
-
Japan's 'godless' lake warns of creeping climate change
-
US teen Lutkenhaus breaks world junior indoor 800m record
-
World copper rush promises new riches for Zambia
-
Paw patrol: Larry the cat marks 15 years at 10 Downing Street
-
India plans AI 'data city' on staggering scale
-
Jamaica's Thompson-Herah runs first race since 2024
-
Crash course: Vietnam's crypto boom goes bust
-
Ahead of Oscars, Juliette Binoche hails strength of Cannes winners
-
US cattle farmers caught between high costs and weary consumers
-
New York creatives squeezed out by high cost of living
-
Lillard matches NBA 3-point contest mark in injury return
-
NBA mulling 'every possible remedy' as 'tanking' worsens
-
Team USA men see off dogged Denmark in Olympic ice hockey
-
'US-versus-World' All-Star Game divides NBA players
-
Top seed Fritz beats Cilic to reach ATP Dallas Open final
-
Lens run riot to reclaim top spot in Ligue 1, Marseille slip up
-
Last-gasp Zielinski effort keeps Inter at Serie A summit
-
Vinicius bags brace as Real Madrid take Liga lead, end Sociedad run
-
Liverpool beat Brighton, Man City oust Beckham's Salford from FA Cup
-
Australia celebrate best-ever Winter Olympics after Anthony wins dual moguls
-
Townsend becomes a fan again as Scotland stun England in Six Nations
-
France's Macron urges calm after right-wing youth fatally beaten
-
China's freeski star Gu recovers from crash to reach Olympic big air final
-
Charli XCX 'honoured' to be at 'political' Berlin Film Festival
-
Relatives of Venezuela political prisoners begin hunger strike
-
Trump's 'desire' to own Greenland persists: Danish PM
-
European debate over nuclear weapons gains pace
-
Newcastle oust 10-man Villa from FA Cup, Man City beat Beckham's Salford
-
Auger-Aliassime swats aside Bublik to power into Rotterdam final
-
French prosecutors announce special team for Epstein files
-
Tuipulotu 'beyond proud' as Scotland stun England
-
Jones strikes twice as Scotland end England's unbeaten run in style
-
American Stolz wins second Olympic gold in speed skating
-
Marseille start life after De Zerbi with Strasbourg draw
-
ECB to extend euro backstop to boost currency's global role
-
Canada warned after 'F-bomb' Olympics curling exchange with Sweden
-
Ultra-wealthy behaving badly in surreal Berlin premiere
-
250,000 at rally in Germany demand 'game over' for Iran's leaders
-
UK to deploy aircraft carrier group to Arctic this year: PM
-
Zelensky labels Putin a 'slave to war'
-
Resurgent Muchova beats Mboko in Qatar final to end title drought
-
Farrell hails Ireland's 'unbelievable character' in edgy Six Nations win
-
Markram, Jansen lead South Africa to brink of T20 Super Eights
-
Guehi scores first Man City goal to kill off Salford, Burnley stunned in FA Cup
-
Swiss say Oman to host US-Iran talks in Geneva next week
-
Kane brace helps Bayern widen gap atop Bundesliga
-
Ireland hold their nerve to beat gallant Italy in Six Nations thriller
-
European states say Navalny poisoned with dart frog toxin in Russian prison
Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage
WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that a third-party evaluation has confirmed key advantages for its Cellinity battery technology's use in grid-scale battery energy storage applications.
The evaluation was conducted by U.S. BESS Corporation (www.usbesscorp.com), an expert provider of advanced energy storage solutions for critical infrastructure applications spanning utilities, defense, microgrids, and heavy industry.
U.S. BESS senior technical staff performed an examination of Cellinity's design and assembly protocols, inspection of testing infrastructure, review of data from test results, and an assessment of methodologies used for performance characterization, concluding that the following performance characteristics exclusive of any auxiliary systems are supported by their observations and are reasonably representative of the current Cellinity cell's demonstrated behavior:
Open circuit voltage: > 4.2 V
Operating temperature range: from 120°C to 250°C
Energy density: > 500 Wh/kg (calculated based on active material)
Power density: > 500 mW/cm3 (maximum observed value of 1579 W/kg at 230°C)
Charge capacity: Cell can be charged to 100% of theoretical capacity
Charge/discharge efficiency: ~100%
Energy efficiency: 95% at 230°C; 87% at 120°C
Self-discharge: No measurable self-discharge observed over test durations
Thermal cycling durability: Performance unaffected after repeated cycling
U.S. BESS Corp further concluded that it is reasonable to claim that a) the cell would not experience any thermal runaway, b) materials of construction are commonly available and can be domestically sourced, c) the cell does not contain any rare earth elements, and d) cell components are fully recyclable.
A Market Ready for Disruption
The global demand for grid-scale energy storage is rapidly growing to meet the rising loads driven by artificial intelligence, decarbonization mandates, and accelerated adoption of renewables. In 2024 alone, the U.S. Energy Information Administration (www.eia.gov) reported a 66% increase in U.S. battery energy storage capacity. While lithium-ion batteries currently dominate the market, they present known challenges: fire risks from thermal runaway, efficiency losses over time, and sourcing constraints related to rare and critical minerals.
BioLargo's Cellinity battery technology (www.biolargoenergy.com) overcomes these limitations by leveraging novel materials and architecture to deliver both exceptional thermal performance and operational efficiencywithout relying on rare earth elements.
Validation Supports Commercial Pathway
The U.S. BESS report concludes: "Based on our inspection and the evidence provided, U.S. BESS finds that the Cellinity Cell demonstrates a sufficient performance profile, with strong indications of high thermal stability, efficiency, energy and power density, and material sustainability, to suggest further investment in testing and commercialization. These attributes position this technology as a potential solution for critical gaps in grid-scale energy storage markets."
Randall Moore, Chief Technology Officer at BioLargo Energy Technologies, Inc., commented, "Our work to scale up the cell design, refine manufacturing techniques, and integrate cells into a functional module for commercial scale testing is underway."
CEO, Dennis P. Calvert commented, "We do not know of any long duration energy storage technology that can match Cellinity's technical claims for cost effective performance and safety. This third-party evaluation is an important piece of the puzzle for our business plan to bring Cellinity to the world through manufacturing joint ventures. We have several of these in development with potential partners and look forward to sharing more intel about those soon."
About U.S. BESS Corp
U.S. BESS Corp is a U.S.-based company that provides energy storage solutions for a wide range of applications, including utilities, industrial needs, microgrids and defense. With decades of combined experience in battery engineering, microgrid deployment, system-level integration, and manufacturing, the company's leadership team is uniquely qualified in the battery energy storage system industry. U.S. BESS is creating the most advanced and secure battery management system and building the largest domestic battery supply in the USA.
U.S. BESS Corp Contact Information
Mark Hagedorn
CEO, U.S. BESS Corp.
503-720-9569
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
BioLargo Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
P.Silva--AMWN